| Non-Alcoholic Fatty Liver Disease |
1 |
1 |
| Metabolic Syndrome |
0 |
0.93 |
| Metabolic Liver Disease |
0 |
0.87 |
| Biliary Disease |
0 |
0.83 |
| Alcoholism |
0 |
0.73 |
| Liver Disease |
0 |
0.72 |
| Liver |
0 |
0.6 |
| Alcoholic Hepatic Steatosis |
0 |
0.55 |
| Fatty Liver |
0 |
0.55 |
| Addiction |
0 |
0.54 |
| Metabolism |
0 |
0.54 |
| Aminotransferase |
0 |
0.48 |
| Hepatocellular Carcinoma |
0 |
0.39 |
| Obesity |
0 |
0.38 |
| Type 2 Diabetes Mellitus |
0 |
0.16 |
| Genomic Medicine |
0 |
0.14 |
| Cirrhosis |
0 |
0.12 |
| Genetics |
0 |
0.12 |
| Pathogenesis |
0 |
0.12 |
| Chronic Kidney Disease |
0 |
0.1 |
| Renal Failure |
0 |
0.1 |
| Renal Disease |
0 |
0.09 |
| Renal Cell Carcinoma |
0 |
0.07 |
| Bile |
0 |
0.06 |
| Body Mass Index |
0 |
0.06 |
| Cancer |
0 |
0.06 |
| Cardiovascular disease |
0 |
0.06 |
| Cardiovascular Risk Management |
0 |
0.06 |
| Diet |
0 |
0.06 |
| Hospital |
0 |
0.06 |
| Kidney |
0 |
0.06 |
| Microbiome |
0 |
0.06 |
| Muscular Atrophy |
0 |
0.06 |
| Sarcopenia |
0 |
0.06 |
| Tobacco Cessation |
0 |
0.06 |
| Tobacco Use |
0 |
0.06 |